40
SYSTEMIC RETINOIDS

Systemic retinoids in dermatology

Embed Size (px)

DESCRIPTION

 

Citation preview

  • 1. SYSTEMIC RETINOIDS
  • 2. The term retinoids includes all natural and synthetic compounds that have structural or biological activities like vitamin A There are more than 1500 retinoids have been developed First generation(nonaromatic): Tretinone: all-trans retinoic acid , Isotretinoin : 13-cis retinoic acid, Alitretinoin: 9-cis retinoic acid Second generation(monoaromatic): Etretinate, acitretin Third generation(polyaromatic): Adapalene, Tazarotene, Bexarotene The original second generation retinoid used for psoriasis, etretinate, was superseded by its natural metabolite, acitretin, which was shown to have similar efficacy with a better pharmacokinetic profile
  • 3. Approved Systemic Retinoids Chemical name Trade name Date approval Indication (removal) Isotretinoin Accutane 5/7/1982 Amnesteem 11/2002 Sotret 12/2002 Claravis 4/2003 Etretinate Tegison 9/30/1986 (12/20/2002) Severe recalcitrant psoriasis Acitretin Soriatane 10/26/1996 Severe psoriasis Bexarotene Targretin 12/29/1999 Refractory CTCL Severe recalcitrant nodular acne 4
  • 4. Retinoids metabolism occurs in the liver They are excreted in bile and urine
  • 5. Mechanism of action These synthetic hormones bind to nuclear retinoid receptors , thereby altering gene transcription and returning keratinocyte proliferation and differentiation to normal. As well as modification of inflammatory responses and neutrophil function
  • 6. Mayor Retinoid-Responsive Skin Diseases Acne: I,(T) Psoriasis: E Disorders of keratinization:I,E,(T) NMSC:I,E Precancerous lesions: T,E,(I) Skin aging:T
  • 7. Psoriasis Retinoids , since they are not immunosuppressive, retinoids have a role in the treatment of psoriasis in children, patients with HIV infection and those who are prone to cancer. It is generally safe for long-term use and has no time limit restrictions. Retinoids are considered excellent for use in combination with other treatments and when used with UVB or PUVA, their dose and the number of phototherapy treatments can be reduced, with the added benefit of a potential reduction in skin carcinogenesis
  • 8. Acitretin is as effective as etretinate . Plaque psoriasis : variable response: 30% complete clearance, 50% significant improvement (60-70% reduction of PASI score) Erythrodermic and Pustular psoriasis: retinoids are the first-line therapy Complete clearance usually requires a combination of therapy such as: 1. Retinoids + topical steroids 2. Retinoids + topical vit D derivatives 3. Retinoids + anthralin 4. Retinoids + PUVA (Re-PUVA): retinoids are started for 14 days before starting PUVA 5. Retinoids + UVB
  • 9. Psoriasis Within few days of initiating therapy at dose 30-70mg/day An initial worsening of the disease with increase of erythema and/or extent of involvement Initial low dose: 10 mg/day Followed by increasing of dose Efficacy of low-dose acitretin is as placebo Effective doses 25,50,75 mg /day (0.5-1 mg/kg/day)
  • 10. Disorders of keratinization Ichthyosis PRP Darier disease Keratoderma Papillon-Lefevre syndrome Keratosis lichenoids chronica
  • 11. PRP Systemic Vitamin A had been used with considerable effectiveness. The advent of synthetic retinoids has largely supplanted vitamin A therapy Isotretinoin: Acitretin 1mg/kg/day 1mg/kg/day 80% of patients showed clearance of lesions after an average 25 weeks treatment Alone or in combination with UVR
  • 12. Acne vulgaris Isotretinoin is a systemic retinoid that is highly effective in the treatment of acne vulgaris. Isotretinoin causes normalization of epidermal differentiation, depresses sebum excretion by 70%, is anti-inflammatory, and even reduces the presence of P acnes. Treatment with isotretinoin can lead to both marked improvement and long-lasting remission. Essentially, isotretinoin has the capacity to cure acne.
  • 13. Initially with the introduction of isotretinoin, only patients with severe nodular cystic acne or severe inflammatory acne, who were not responding to conventional therapy were given the drug. Now, with more than 20 years of treatment experience, expanded guidelines for its use include: 1. Moderate acne relapse (